Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Post by Don2018on Dec 06, 2019 8:38pm
208 Views
Post# 30431192

Condensate was $82.28 today

Condensate was $82.28 todayWhile PIPE's budget is based on $69.67 for condensate.

That is an extra $29 MILLION of annualized revenue, EXTRA revenue above and beyond their guidance. And that is only based on 2019 exit production. As we all know, their intentions are to continue to raise production until we get to that target of 33,000 boed.

That $29 million (and growing) extra cash flow would pay for an extra 5 wells, above the number they can already drill with free cash flow. That should be enough to get us well over the 20,000 boed level in 2020, which just means even higher cash flow.

With OPEC providing support for the price of oil, and condensate continuing to command a huge premium to other liquids in Western Canada, PIPE finds itself in a very enviable, and profitable, position.
<< Previous
Bullboard Posts
Next >>